EC
RGEN icon

EntryPoint Capital’s Repligen RGEN Stock Holding History

EntryPoint Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,153
Closed -$469K – 928
2024
Q3 		$469K Buy
3,153
+532
+20% +$76.3K 0.27% 68
2024
Q2 		$330K Buy
+2,621
New +$411K 0.15% 139

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

EntryPoint Capital's RGEN Position: Q4 2024 in Review

EntryPoint Capital sold out of Repligen (RGEN) in Q4 2024, closing a stake of 3,153 shares — an estimated $469K sold.

EntryPoint Capital first reported a position in RGEN in Q2 2024 and held it in 2 quarters. The position peaked at $469K in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • EntryPoint Capital reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • EntryPoint Capital sold 3,153 Repligen shares in Q4 2024, an estimated $469K.
  • EntryPoint Capital first reported a position in Repligen in Q2 2024 and held it in 2 quarters.
  • EntryPoint Capital's Repligen position peaked at $469K in Q3 2024.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.